Article Details

Imugene doses first patient in Phase 1 clinical trial of checkpoint immunotherapy candidate PD1 ...

Retrieved on: 2020-11-30 23:37:30

Tags for this article:

Click the tags to see associated articles and topics

Imugene doses first patient in Phase 1 clinical trial of checkpoint immunotherapy candidate PD1 .... View article details on hiswai:

Excerpt

... to Keytruda, Opdivo and the other immune checkpoint inhibitor <b>monoclonal</b> <b>antibodies</b> that are transforming the treatment of a range of cancers.

Article found on: www.proactiveinvestors.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo